APA (7th ed.) Citation

Borlak, J., Ciribilli, Y., Bisio, A., Selvaraj, S., Inga, A., Oh, J., & Spanel, R. (2024). The Abl1 tyrosine kinase is a key player in doxorubicin-induced cardiomyopathy and its p53/p73 cell death mediated signaling differs in atrial and ventricular cardiomyocytes. Journal of Translational Medicine, 22(1), 1. https://doi.org/10.1186/s12967-024-05623-8

Chicago Style (17th ed.) Citation

Borlak, Jürgen, Yari Ciribilli, Alessandra Bisio, Saravanakumar Selvaraj, Alberto Inga, Jung-Hwa Oh, and Reinhard Spanel. "The Abl1 Tyrosine Kinase Is a Key Player in Doxorubicin-induced Cardiomyopathy and Its P53/p73 Cell Death Mediated Signaling Differs in Atrial and Ventricular Cardiomyocytes." Journal of Translational Medicine 22, no. 1 (2024): 1. https://doi.org/10.1186/s12967-024-05623-8.

MLA (9th ed.) Citation

Borlak, Jürgen, et al. "The Abl1 Tyrosine Kinase Is a Key Player in Doxorubicin-induced Cardiomyopathy and Its P53/p73 Cell Death Mediated Signaling Differs in Atrial and Ventricular Cardiomyocytes." Journal of Translational Medicine, vol. 22, no. 1, 2024, p. 1, https://doi.org/10.1186/s12967-024-05623-8.